An experimental vaccine for kidney cancer is off to a promising start.
Since the trial patients received the vaccine roughly three years ago, they have stayed cancer-free.
Vaccines are generally designed to train a persons immune system against future threats like the flu or measles.
Two vials of a vaccine.© MirageC via Getty
There are some vaccines, like the HPV jab, that are highly effective at preventing cancer-causing infections.
Butcancer vaccinesare more often therapeutic, helping treat someones ongoing cancer or trying to prevent reoccurrences.
Choueiris team includes researchers from the Broad Institute of MIT and Harvard University.
The teams vaccine targets advanced kidney cancers that have begun to spread elsewhere.
The researchers personalized the vaccines given to their patients.
So far, the results are highly encouraging.
But the results indicate that even these cancers can now be a viable target for neoantigen vaccines.
And the research team is already working on thenext phaseof its vital research.
News from the future, delivered to your present.